Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Active as of 2022-01-10 |
{
"resourceType" : "Citation",
"id" : "58",
"meta" : {
"versionId" : "25",
"lastUpdated" : "2024-11-16T19:17:38.652Z"
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Citation 58</b></p><a name=\"58\"> </a><a name=\"hc58\"> </a><a name=\"58-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 25; Last updated: 2024-11-16 19:17:38+0000</p></div><p><b>url</b>: <a href=\"Citation-58.html\">Citation Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</a></p><p><b>identifier</b>: FEvIR Object Identifier/https://fevir.net/FOI/58, <a href=\"http://terminology.hl7.org/6.1.0/NamingSystem-uri.html\" title=\"As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt \r\n\r\nThis oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: \r\n\r\nNote that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.\r\n\r\nThis OID may also be used in CD.codeSystem.\">Uniform Resource Identifier (URI)</a>/urn:oid:2.16.840.1.113883.4.642.40.44.15.20</p><p><b>version</b>: 2.0.0-ballot</p><p><b>title</b>: Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</p><p><b>status</b>: Active</p><p><b>date</b>: 2022-01-10 13:29:15+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href=\"http://www.hl7.org/Special/committees/dss\">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: </p><div><p>This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>\n</div><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-citation-classification-type.html#citation-classification-type-fevir-platform-use\">Citation Classification Type fevir-platform-use</a>: FEvIR Platform Use</td><td><span title=\"Codes:{http://hl7.org/fhir/citation-artifact-classifier fhir-resource}\">FHIR Resource</span></td></tr></table><p><b>jurisdiction</b>: <span title=\"Codes:{http://unstats.un.org/unsd/methods/m49/m49.htm 001}\">World</span></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>author</b>: Brian S. Alper: </p><h3>Summaries</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Style</b></td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://hl7.org/fhir/citation-summary-style comppub}\">Computable Publishing</span></td><td><div><p>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55.</p>\n</div></td></tr></table><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>ResourceReference</b></td></tr><tr><td style=\"display: none\">*</td><td>Derived From</td><td><a href=\"Evidence-55.html\">14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</a></td></tr></table><blockquote><p><b>citedArtifact</b></p><p><b>identifier</b>: FEvIR Object Identifier/55</p><p><b>dateAccessed</b>: 2021-03-13</p><h3>Versions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Value</b></td></tr><tr><td style=\"display: none\">*</td><td>4</td></tr></table><h3>StatusDates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Activity</b></td><td><b>Actual</b></td><td><b>Period</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://hl7.org/fhir/cited-artifact-status-type created}\">Created</span></td><td>true</td><td>?? --> 2020-12-17</td></tr></table><h3>Titles</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://hl7.org/fhir/title-type primary}\">Primary title</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 en}\">English</span></td><td><div><p>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY).</p>\n</div></td></tr></table><h3>Abstracts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td><td><b>Copyright</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://hl7.org/fhir/cited-artifact-abstract-type primary-human-use}\">Primary human use</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 en}\">English</span></td><td><div><p>COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis</p>\n</div></td><td><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div></td></tr></table><blockquote><p><b>publicationForm</b></p><h3>PublishedIns</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Title</b></td><td><b>Publisher</b></td><td><b>PublisherLocation</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://hl7.org/fhir/published-in-type D019991}\">Database</span></td><td>Fast Evidence Interoperability Resources (FEvIR) Platform</td><td>Computable Publishing LLC</td><td>Ipswich, MA, USA</td></tr></table><p><b>lastRevisionDate</b>: 2020-12-21</p><p><b>language</b>: <span title=\"Codes:{urn:ietf:bcp:47 en}\">English</span></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div></blockquote><blockquote><p><b>webLocation</b></p><p><b>classifier</b>: <span title=\"Codes:{http://hl7.org/fhir/artifact-url-classifier json}\">JSON</span>, <span title=\"Codes:{http://hl7.org/fhir/artifact-url-classifier computable-resource}\">Computable resource</span></p><p><b>url</b>: <a href=\"https://fevir.net/resources/Evidence/55\">https://fevir.net/resources/Evidence/55</a></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/cited-artifact-classification-type knowledge-artifact-type}\">Knowledge Artifact Type</span></p><p><b>classifier</b>: <span title=\"Codes:{http://hl7.org/fhir/citation-artifact-classifier fhir-resource}\">FHIR Resource</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title=\"Codes:\">fhir-resource</span></p><p><b>classifier</b>: <span title=\"Codes:{http://hl7.org/fhir/fhir-types Evidence}\">Evidence</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title=\"Codes:\">defined-in-text</span></p><p><b>classifier</b>: <span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}\">remdesivir</span>, <span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}\">COVID-19</span>, <span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}\">pharmaceutical treatment</span></p></blockquote><blockquote><p><b>contributorship</b></p><p><b>complete</b>: true</p><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href=\"#hc58/contributor0\">Practitioner Brian S. Alper </a></p><p><b>forenameInitials</b>: BS</p><p><b>affiliation</b>: Computable Publishing LLC</p><p><b>contributionType</b>: <span title=\"Codes:{http://hl7.org/fhir/artifact-contribution-type conceptualization}\">Conceptualization</span>, <span title=\"Codes:{http://hl7.org/fhir/artifact-contribution-type data-curation}\">Data curation</span>, <span title=\"Codes:{http://hl7.org/fhir/artifact-contribution-type supervision}\">Supervision</span></p><p><b>role</b>: <span title=\"Codes:{http://hl7.org/fhir/contributor-role author}\">Author/Creator</span></p><p><b>correspondingContact</b>: true</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href=\"#hc58/contributor1\">Practitioner Joanne Dehnbostel </a></p><p><b>forenameInitials</b>: J</p><p><b>affiliation</b>: Computable Publishing LLC</p><p><b>contributionType</b>: <span title=\"Codes:{http://hl7.org/fhir/artifact-contribution-type formal-analysis}\">Formal analysis</span>, <span title=\"Codes:{http://hl7.org/fhir/artifact-contribution-type data-curation}\">Data curation</span></p><p><b>role</b>: <span title=\"Codes:{http://hl7.org/fhir/contributor-role author}\">Author/Creator</span></p><p><b>correspondingContact</b>: false</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href=\"#hc58/contributor2\">Practitioner Khalid Shahin </a></p><p><b>forenameInitials</b>: K</p><p><b>affiliation</b>: Computable Publishing LLC</p><p><b>contributionType</b>: <span title=\"Codes:{http://hl7.org/fhir/artifact-contribution-type software}\">Software</span></p><p><b>role</b>: <span title=\"Codes:{http://hl7.org/fhir/contributor-role author}\">Author/Creator</span></p><p><b>correspondingContact</b>: false</p></blockquote></blockquote></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Practitioner #contributor0</b></p><a name=\"58/contributor0\"> </a><a name=\"hc58/contributor0\"> </a><a name=\"58/contributor0-en-US\"> </a><p><b>identifier</b>: <code>https://orcid.org/</code>/0000-0003-4300-4928</p><p><b>name</b>: Brian S. Alper </p><p><b>telecom</b>: <a href=\"mailto:balper@computablepublishing.com\">balper@computablepublishing.com</a></p></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Practitioner #contributor1</b></p><a name=\"58/contributor1\"> </a><a name=\"hc58/contributor1\"> </a><a name=\"58/contributor1-en-US\"> </a><p><b>name</b>: Joanne Dehnbostel </p><p><b>telecom</b>: <a href=\"mailto:jdehnbostel@computablepublishing.com\">jdehnbostel@computablepublishing.com</a></p></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Practitioner #contributor2</b></p><a name=\"58/contributor2\"> </a><a name=\"hc58/contributor2\"> </a><a name=\"58/contributor2-en-US\"> </a><p><b>name</b>: Khalid Shahin </p><p><b>telecom</b>: <a href=\"mailto:kshahin@computablepublishing.com\">kshahin@computablepublishing.com</a></p></blockquote></div>"
},
"contained" : [
{
"resourceType" : "Practitioner",
"id" : "contributor0",
"identifier" : [
{
"system" : "https://orcid.org/",
"value" : "0000-0003-4300-4928",
"assigner" : {
"display" : "ORCID"
}
}
],
"name" : [
{
"family" : "Alper",
"given" : [
"Brian S."
]
}
],
"telecom" : [
{
"system" : "email",
"value" : "balper@computablepublishing.com"
}
]
},
{
"resourceType" : "Practitioner",
"id" : "contributor1",
"name" : [
{
"family" : "Dehnbostel",
"given" : [
"Joanne"
]
}
],
"telecom" : [
{
"system" : "email",
"value" : "jdehnbostel@computablepublishing.com"
}
]
},
{
"resourceType" : "Practitioner",
"id" : "contributor2",
"name" : [
{
"family" : "Shahin",
"given" : [
"Khalid"
]
}
],
"telecom" : [
{
"system" : "email",
"value" : "kshahin@computablepublishing.com"
}
]
}
],
"url" : "https://fevir.net/resources/Citation/58",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "urn:ietf:rfc:3986",
"value" : "https://fevir.net/FOI/58",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.40.44.15.20"
}
],
"version" : "2.0.0-ballot",
"title" : "Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)",
"status" : "active",
"date" : "2022-01-10T13:29:15.764Z",
"publisher" : "HL7 International / Clinical Decision Support",
"contact" : [
{
"name" : "HL7 International / Clinical Decision Support",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/dss"
}
]
}
],
"description" : "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"useContext" : [
{
"code" : {
"system" : "http://hl7.org/fhir/citation-classification-type",
"code" : "fevir-platform-use",
"display" : "FEvIR Platform Use"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/citation-artifact-classifier",
"code" : "fhir-resource",
"display" : "FHIR Resource"
}
]
}
}
],
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001",
"display" : "World"
}
]
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"author" : [
{
"name" : "Brian S. Alper"
}
],
"summary" : [
{
"style" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/citation-summary-style",
"code" : "comppub",
"display" : "Computable Publishing"
}
]
},
"text" : "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55."
}
],
"relatedArtifact" : [
{
"type" : "derived-from",
"resourceReference" : {
🔗 "reference" : "Evidence/55",
"type" : "Evidence",
"display" : "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"
}
}
],
"citedArtifact" : {
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "55",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"dateAccessed" : "2021-03-13",
"version" : {
"value" : "4"
},
"statusDate" : [
{
"activity" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/cited-artifact-status-type",
"code" : "created",
"display" : "Created"
}
]
},
"actual" : true,
"period" : {
"end" : "2020-12-17"
}
}
],
"title" : [
{
"type" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/title-type",
"code" : "primary",
"display" : "Primary title"
}
]
}
],
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"version" : "4.0.1",
"code" : "en",
"display" : "English"
}
]
},
"text" : "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)."
}
],
"abstract" : [
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/cited-artifact-abstract-type",
"code" : "primary-human-use",
"display" : "Primary human use"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "en",
"display" : "English"
}
]
},
"text" : "COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis",
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/"
}
],
"publicationForm" : [
{
"publishedIn" : {
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/published-in-type",
"code" : "D019991",
"display" : "Database"
}
]
},
"title" : "Fast Evidence Interoperability Resources (FEvIR) Platform",
"publisher" : {
"type" : "Organization",
"display" : "Computable Publishing LLC"
},
"publisherLocation" : "Ipswich, MA, USA"
},
"lastRevisionDate" : "2020-12-21",
"language" : [
{
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"version" : "4.0.1",
"code" : "en",
"display" : "English"
}
]
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/"
}
],
"webLocation" : [
{
"classifier" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-url-classifier",
"code" : "json",
"display" : "JSON"
}
]
},
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-url-classifier",
"code" : "computable-resource",
"display" : "Computable resource"
}
]
}
],
"url" : "https://fevir.net/resources/Evidence/55"
}
],
"classification" : [
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/cited-artifact-classification-type",
"code" : "knowledge-artifact-type",
"display" : "Knowledge Artifact Type"
}
]
},
"classifier" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/citation-artifact-classifier",
"code" : "fhir-resource",
"display" : "FHIR Resource"
}
]
}
]
},
{
"type" : {
"text" : "fhir-resource"
},
"classifier" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/fhir-types",
"code" : "Evidence",
"display" : "Evidence"
}
]
}
]
},
{
"type" : {
"text" : "defined-in-text"
},
"classifier" : [
{
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "defined-in-text",
"display" : "Defined in text"
}
],
"text" : "remdesivir"
},
{
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "defined-in-text",
"display" : "Defined in text"
}
],
"text" : "COVID-19"
},
{
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "defined-in-text",
"display" : "Defined in text"
}
],
"text" : "pharmaceutical treatment"
}
]
}
],
"contributorship" : {
"complete" : true,
"entry" : [
{
"contributor" : {
"reference" : "#contributor0",
"type" : "Practitioner"
},
"forenameInitials" : "BS",
"affiliation" : [
{
"display" : "Computable Publishing LLC"
}
],
"contributionType" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "conceptualization",
"display" : "Conceptualization"
}
]
},
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "data-curation",
"display" : "Data curation"
}
]
},
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "supervision",
"display" : "Supervision"
}
]
}
],
"role" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/contributor-role",
"code" : "author",
"display" : "Author/Creator"
}
]
},
"correspondingContact" : true
},
{
"contributor" : {
"reference" : "#contributor1",
"type" : "Practitioner"
},
"forenameInitials" : "J",
"affiliation" : [
{
"display" : "Computable Publishing LLC"
}
],
"contributionType" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "formal-analysis",
"display" : "Formal analysis"
}
]
},
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "data-curation",
"display" : "Data curation"
}
]
}
],
"role" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/contributor-role",
"code" : "author",
"display" : "Author/Creator"
}
]
},
"correspondingContact" : false
},
{
"contributor" : {
"reference" : "#contributor2",
"type" : "Practitioner"
},
"forenameInitials" : "K",
"affiliation" : [
{
"display" : "Computable Publishing LLC"
}
],
"contributionType" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "software",
"display" : "Software"
}
]
}
],
"role" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/contributor-role",
"code" : "author",
"display" : "Author/Creator"
}
]
},
"correspondingContact" : false
}
]
}
}
}
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#2.0.0-ballot based on FHIR 6.0.0-ballot2. Generated 2024-12-19
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change